TY - JOUR
T1 - Opposite physiological and pathological mTORC1-mediated roles of the CB1 receptor in regulating renal tubular function
AU - Hinden, Liad
AU - Ahmad, Majdoleen
AU - Hamad, Sharleen
AU - Nemirovski, Alina
AU - Szanda, Gergő
AU - Glasmacher, Sandra
AU - Kogot-Levin, Aviram
AU - Abramovitch, Rinat
AU - Thorens, Bernard
AU - Gertsch, Jürg
AU - Leibowitz, Gil
AU - Tam, Joseph
N1 - Publisher Copyright:
© 2022, The Author(s).
PY - 2022/4/4
Y1 - 2022/4/4
N2 - Activation of the cannabinoid-1 receptor (CB1R) and the mammalian target of rapamycin complex 1 (mTORC1) in the renal proximal tubular cells (RPTCs) contributes to the development of diabetic kidney disease (DKD). However, the CB1R/mTORC1 signaling axis in the kidney has not been described yet. We show here that hyperglycemia-induced endocannabinoid/CB1R stimulation increased mTORC1 activity, enhancing the transcription of the facilitative glucose transporter 2 (GLUT2) and leading to the development of DKD in mice; this effect was ameliorated by specific RPTCs ablation of GLUT2. Conversely, CB1R maintained the normal activity of mTORC1 by preventing the cellular excess of amino acids during normoglycemia. Our findings highlight a novel molecular mechanism by which the activation of mTORC1 in RPTCs is tightly controlled by CB1R, either by enhancing the reabsorption of glucose and inducing kidney dysfunction in diabetes or by preventing amino acid uptake and maintaining normal kidney function in healthy conditions.
AB - Activation of the cannabinoid-1 receptor (CB1R) and the mammalian target of rapamycin complex 1 (mTORC1) in the renal proximal tubular cells (RPTCs) contributes to the development of diabetic kidney disease (DKD). However, the CB1R/mTORC1 signaling axis in the kidney has not been described yet. We show here that hyperglycemia-induced endocannabinoid/CB1R stimulation increased mTORC1 activity, enhancing the transcription of the facilitative glucose transporter 2 (GLUT2) and leading to the development of DKD in mice; this effect was ameliorated by specific RPTCs ablation of GLUT2. Conversely, CB1R maintained the normal activity of mTORC1 by preventing the cellular excess of amino acids during normoglycemia. Our findings highlight a novel molecular mechanism by which the activation of mTORC1 in RPTCs is tightly controlled by CB1R, either by enhancing the reabsorption of glucose and inducing kidney dysfunction in diabetes or by preventing amino acid uptake and maintaining normal kidney function in healthy conditions.
UR - http://www.scopus.com/inward/record.url?scp=85127520822&partnerID=8YFLogxK
U2 - 10.1038/s41467-022-29124-8
DO - 10.1038/s41467-022-29124-8
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 35379807
AN - SCOPUS:85127520822
SN - 2041-1723
VL - 13
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 1783
ER -
